An Analytical Reference Standard
Features
  • This product has been formulated as an exempt preparation which meets criteria established by the US DEA
  • Possession of a DEA Controlled Substance registration is not necessary nor is a DEA 222 form required to purchase this product
  • This product is intended to be used as an analytical reference standard
  • Bulk material is available for academic research at qualified institutions; please contact our sales department for pricing
Related Products
Non-Exempt Preparation(s)
37040(−)-11-hydroxy-Δ8-THC-d3
Unlabeled Version(s)
29469(−)-11-hydroxy-Δ8-THC
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

(−)-11-hydroxy-Δ8-THC-d3 (exempt preparation)

Item No. 40976

Exempt Product (US)
Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Synonyms
Synonyms
  • (−)-11-hydroxy-Δ8-Tetrahydrocannabinol-d3
  • (−)-trans-Δ8-THC-d3
  • 7-hydroxy-Δ6-THC-d3
Technical Information
Formal Name
(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(pentyl-5,5,5-d3)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol
Molecular Formula
C21H27D3O3
Formula Weight
333.5
Purity
≥99% deuterated forms (d1-d3)
Formulation
A 100 µg/ml solution in methanol
SMILES
[H][C@]12C3=C(C=C(CCCCC([2H])([2H])[2H])C=C3O)OC(C)(C)[C@]1([H])CC=C(CO)C2
InChi Code
InChI=1S/C21H30O3/c1-4-5-6-7-14-11-18(23)20-16-10-15(13-22)8-9-17(16)21(2,3)24-19(20)12-14/h8,11-12,16-17,22-23H,4-7,9-10,13H2,1-3H3/t16-,17-/m1/s1/i1D3
InChi Key
LOUSQMWLMDHRIK-MVOYJBSWSA-N
Regulatory Information
DEA Exempt Notification
This product is a DEA exempt preparation of a scheduled compound - does not require DEA Controlled Substance registration or DEA 222 form. For alternate sizes please contact sales.
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    100 µg

    $252

    Add
    Cayman Chemical
    Explore All Cannabis Testing Resources
    Fit-for-Purpose CRMs & Analytical Standards
    • Major & minor phytocannabinoids
    • Novel cannabinoids
    • Terpenes & flavonoids
    • Pesticides, mycotoxins, & residual solvents
    LEARN MORE
    Product Description

    (−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) (Item No. 40976) is intended for use as an internal standard for the quantification of (−)-11-hydroxy-Δ8-THC (Item No. 29469) by GC- or LC-MS. (−)-11-hydroxy-Δ8-THC is categorized as a phytocannabinoid metabolite.1,2 (–)-11-hydroxy-Δ8-THC is a metabolite of Δ8-THC (Item Nos. ISO60158 | 14042). It has analgesic activity in mice. (–)-11-hydroxy-Δ8-THC-d3 is regulated as a Schedule I compound in the United States. (−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) (Item No. 40976) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Watanabe, K., Yamamoto, I., Oguri, K., et al. Comparison in mice of pharmacological effects of Δ8-tetrahydrocannabinol and its metabolites oxidized at 11-position. Eur. J. Pharm. 63(1), 1-6 (1980).

    2. Rhee, M.H., Vogel, Z., Barg, J., et al. Cannabinol derivatives: Binding to cannabinoid receptors and inhibition of adenylylcyclase. J. Med. Chem. 40(20), 3228-3233 (1997).